Illustration: Aïda Amer/Axios

Policy responses to the global coronavirus crisis have been every-country-for-itself and — in the case of the U.S. and China — tinged with geopolitics.

The flipside: The scientific work underway to understand the virus and develop a vaccine has been globalized on an unprecedented scale.

Zoom in: Trump has boasted that in the race toward a vaccine, “America will get it done!”

  • But the NY Times reports that a University of Pittsburgh lab on the cutting edge of vaccine research is collaborating with a research institute in Paris and a drug company in Austria. That group gets funding from an international organization based in Norway and is in talks about vaccine development with a major Indian manufacturer.
  • Chinese researchers have contributed much of the coronavirus research now available to other scientists, the Times notes. And a team at Mass General hospital in Boston is testing possible treatments in conjunction with colleagues in Xi’an, China.

The good news: The global scientific community has perhaps never been so singularly devoted to one issue, and borders have not been a major barrier to that work.

But, but, but: Nationalism and geopolitics could still come into play in the eventual distribution of a vaccine, Axios’ Alison Snyder notes.

  • There is a concern that the first countries to develop or obtain one could prioritize their own populations, and the vaccine would only reach some countries significantly later.

Go deeper

Dion Rabouin, author of Markets
1 hour ago - Economy & Business

Investors are betting the future is priced in euros

Illustration: Aïda Amer/Axios

It's the euro's time now — at least that's how investors have been positioning recently.

What's happening: Speculators have raised their bets to the highest in nine years that the dollar will fall and increased bullish bets that the euro will rise to the highest level on record, Reuters reported citing data from the CFTC.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Global: Total confirmed cases as of 9 a.m. ET: 20,372,619 — Total deaths: 743,344— Total recoveries: 12,609,775Map.
  2. U.S.: Total confirmed cases as of 9 a.m. ET: 5,141,879 — Total deaths: 164,545 — Total recoveries: 1,714,960 — Total tests: 63,252,257Map.
  3. Business: U.S. already feeling effects of ending unemployment benefits — U.S. producer prices rose last month by the most since October 2018.
  4. Public health: America's flying blind on its coronavirus response.
Mike Allen, author of AM
3 hours ago - Politics & Policy

3 keys to Joe Biden picking Kamala Harris

Photo: Jeff Kowalsky/AFP via Getty Images

Three quick points about Joe Biden's historic selection of Sen. Kamala (pronounced COMMA-luh) Harris of California as his running mate — and clues they give us to how Biden would govern:

  1. She was always at the top of his list. As I look back through my text threads with top Dems over the past five months, she was always assumed to be the most likely pick.